← Return to Brensocatib Aspen Trial Results in NEJM!

Discussion
becleartoday avatar

Brensocatib Aspen Trial Results in NEJM!

MAC & Bronchiectasis | Last Active: Aug 10 9:43pm | Replies (27)
Comment receiving replies
Profile picture for becleartoday @becleartoday

Hi Scoop! Brensocatib had an excellent safety profile. The FDA did not require a committee review because they felt it was that safe. Why do you say it’s better than BI’s? Linda

Jump to this post

Replies to "Hi Scoop! Brensocatib had an excellent safety profile. The FDA did not require a committee review..."
scoop | @scoop | Apr 27 3:58pm

Boehringer-Ingelheim claims their drug has a better safety profile! Healthy competition is great for the patient. Other than pneumonia, severe infection, hyperkeratosis and gingivitis I agree that Brensocatib looks pretty good.

VIEW AND REPLY